Medeze Group Public Company Limited provides health care services. The Company offers cord tissue and adipose tissue, cord blood, and stem cells banking and regenerative medicine services. Medeze Group serves customers in Asia.

Report On The Progress On The Cancellation Of Land Purchase For The Place Of Business Expansion

Financial Statement Quarter 3/2025 (Reviewed)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medeze Group (MEDEZE TB)

Report On The Progress On The Cancellation Of Land Purchase For The Place Of Business Expansion

Financial Statement Quarter 3/2025 (Reviewed)

Financial Performance Quarter 3 (F45) (Reviewed)

Management Discussion And Analysis Quarter 3 Ending 30 Sep 2025

Notification Of The Board Of Directors Meeting'S Resolution Regarding Joint Investment And Establishment Of A Joint Venture Company

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)